We synthesized and investigated the NMDA and σ<sub>1</sub> receptor affinity of enantiomerically pure 2-(2-phenyl-1,3-dioxan-4-yl)ethanamines <b>17</b>–<b>26</b>. The primary amines (<i>R</i>,<i>R</i>)-<b>18</b>–<b>20</b> with an axially oriented phenyl moiety in position 2 interacted with high enantioselectivity (eudismic ratios 70–130) and high affinity (<i>K</i><sub>i</sub>((<i>R</i>,<i>R</i>)-<b>19</b>) = 13 nM) with the PCP binding site of the NMDA receptor. Introduction of an <i>N</i>-benzyl moiety led to potent σ<sub>1</sub> ligands including compound (<i>S</i>,<i>R</i>)-<b>22</b> (<i>K</i><sub>i</sub> = 6 nM) with an equatorially oriented phenyl moiety in position 2
NMDA receptors are glutamate-gated cation channels with high calcium permeability that play importan...
The dopamine receptor system plays a key role in numerous neuropsychiatric and neurological disorder...
12siDepending on the substitution pattern and stereochemistry, 1,3-dioxanes 1 with an aminoethyl moi...
Two series of 1,4-dioxanes (<b>4</b>–<b>11</b> and <b>12</b>–<b>19</b>) were rationally designed and...
Two series of 1,4-dioxanes (4-11 and 12-19) were rationally designed and prepared to interact either...
The dissociative anaesthetics dexoxadrol and etoxadrol behave as potent non-competitive NMDA recepto...
Two series of 1,4-dioxanes (4-11 and 12-19) were rationally designed and prepared to interact either...
Several examples support the concept that modest chemical modifications can drastically alter the bi...
A strategy that can lead to the discovery of novel biologically active compounds, and over the last ...
5-HT<sub>1A</sub> receptor and α<sub>1</sub>-adrenoreceptor (α<sub>1</sub>-AR) binding sites recogni...
A chiral pool synthesis was developed to obtain all four stereoisomeric 2-methyl-3-(4-phenylbutyl)t...
Dopaminergics of types <b>1</b> and <b>2</b> incorporating a conjugated enyne as an atypical catecho...
11si1,3-Dioxanes 1 and cyclohexanes 2 bearing a phenyl ring and an aminoethyl moiety in 1,3-relation...
The potent N-methyl-d-aspartate (NMDA) receptor antagonists 1-3 have been demonstrated to show antip...
5-HT1A receptor and α1-adrenoreceptor (α1-AR) binding sites recognized by the 1,4-dioxanes 2−4 displ...
NMDA receptors are glutamate-gated cation channels with high calcium permeability that play importan...
The dopamine receptor system plays a key role in numerous neuropsychiatric and neurological disorder...
12siDepending on the substitution pattern and stereochemistry, 1,3-dioxanes 1 with an aminoethyl moi...
Two series of 1,4-dioxanes (<b>4</b>–<b>11</b> and <b>12</b>–<b>19</b>) were rationally designed and...
Two series of 1,4-dioxanes (4-11 and 12-19) were rationally designed and prepared to interact either...
The dissociative anaesthetics dexoxadrol and etoxadrol behave as potent non-competitive NMDA recepto...
Two series of 1,4-dioxanes (4-11 and 12-19) were rationally designed and prepared to interact either...
Several examples support the concept that modest chemical modifications can drastically alter the bi...
A strategy that can lead to the discovery of novel biologically active compounds, and over the last ...
5-HT<sub>1A</sub> receptor and α<sub>1</sub>-adrenoreceptor (α<sub>1</sub>-AR) binding sites recogni...
A chiral pool synthesis was developed to obtain all four stereoisomeric 2-methyl-3-(4-phenylbutyl)t...
Dopaminergics of types <b>1</b> and <b>2</b> incorporating a conjugated enyne as an atypical catecho...
11si1,3-Dioxanes 1 and cyclohexanes 2 bearing a phenyl ring and an aminoethyl moiety in 1,3-relation...
The potent N-methyl-d-aspartate (NMDA) receptor antagonists 1-3 have been demonstrated to show antip...
5-HT1A receptor and α1-adrenoreceptor (α1-AR) binding sites recognized by the 1,4-dioxanes 2−4 displ...
NMDA receptors are glutamate-gated cation channels with high calcium permeability that play importan...
The dopamine receptor system plays a key role in numerous neuropsychiatric and neurological disorder...
12siDepending on the substitution pattern and stereochemistry, 1,3-dioxanes 1 with an aminoethyl moi...